Taro Pharmaceutical Industries Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 381 | 0.00101% |
| Individual Insiders | 780 | 0.00208% |
| General Public | 2,889,591 | 7.69% |
| Institutions | 5,196,066 | 13.8% |
| Public Companies | 29,497,813 | 78.5% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 29,497,813 | US$1.2b | 0% | no data | |||
| 646,453 | US$27.2m | 0.89% | 9.55% | |||
| 622,983 | US$26.2m | 7.06% | no data | |||
| 579,400 | US$24.4m | -1.6% | 0.04% | |||
| 545,682 | US$22.9m | -0.77% | no data | |||
| 475,741 | US$20.0m | 0.69% | 0.16% | |||
| 307,225 | US$12.9m | 0.96% | no data | |||
| 255,988 | US$10.8m | 0.26% | 0.88% | |||
| 232,156 | US$9.8m | -11.2% | no data | |||
| 200,965 | US$8.4m | 0% | 0.44% | |||
| 167,782 | US$7.1m | 61.7% | 1.35% | |||
| 163,693 | US$6.9m | 2.24% | no data | |||
| 92,813 | US$3.9m | 4.91% | no data | |||
| 89,475 | US$3.8m | 0% | 0.03% | |||
| 62,080 | US$2.6m | 7.14% | no data | |||
| 55,266 | US$2.3m | -3.99% | 0.01% | |||
| 50,840 | US$2.1m | 5.8% | no data | |||
| 43,394 | US$1.8m | -27.3% | no data | |||
| 42,835 | US$1.8m | -29.5% | no data | |||
| 39,556 | US$1.7m | -44.2% | no data | |||
| 38,585 | US$1.6m | -17.5% | no data | |||
| 33,755 | US$1.4m | 56.3% | no data | |||
| 22,591 | US$949.8k | 1.66% | no data | |||
| 18,686 | US$785.6k | -0.04% | no data | |||
| 18,600 | US$782.0k | -11% | no data |